Activation of the mouse TATA-less and human TATA-containing UDP-glucuronosyltransferase 1A1 promoters by hepatocyte nuclear factor 1

被引:60
|
作者
Bernard, P
Goudonnet, H
Artur, Y
Desvergne, B
Wahli, W
机构
[1] Univ Lausanne, Inst Biol Anim, CH-1015 Lausanne, Switzerland
[2] Univ Bourgogne, Unite Format & Rech Pharm, Lab Biochim Pharmacol, Dijon, France
关键词
D O I
10.1124/mol.56.3.526
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
UDP-glucuronosyltransferase (UGT) 1A1 (UGT1A1) catalyzes the glucuronidation of bilirubin in liver. Among all UGT isoforms identified to date, it is the only relevant bilirubin-glucuronidating enzyme in human. Because glucuronoconjugation is the major route of bilirubin elimination, any genetic alteration that affects bilirubin glucuronosyltransferase activity may result in a more or less severe hyperbilirubinemia. In this study, we report the cloning and characterization of the transcriptional regulation of the mouse UGT1A1 gene, Primary-structure analysis of the mouse Thymidine Adevice promoter revealed marked differences with its human homolog. First, the mouse promoter lacks the highly polymorphic thymidine/adenine repeat occurring in the human promoter, which has been associated with some forms of hyperbilirubinemia. Second, an L1 transposon element, which is absent in the human promoter, is found 480 bp upstream of the transcription start site in mouse. Using the electromobility shift and DNase I footprinting experiments, we have identified a hepatocyte nuclear factor 1-binding site in the mouse UGT1A1 promoter that confers responsiveness to both factors HNF1 alpha and HNF1 beta in HEK293 cells. Furthermore, we show that this element, which is conserved in the human promoter, also confers strong HNF1 responsiveness to the human UGT1A1 gene, Together, these results provide evidence for a major regulatory function of this liver-enriched transcription factor in UGT1A1 activity in both rodents and human.
引用
收藏
页码:526 / 536
页数:11
相关论文
共 50 条
  • [21] Function, Genetic Polymorphism, and Transcriptional Regulation of Human UDP-glucuronosyltransferase (UGT) 1A1
    Sugatani, Junko
    DRUG METABOLISM AND PHARMACOKINETICS, 2013, 28 (02) : 83 - 92
  • [22] Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1
    Xuewei Cheng
    Xia Lv
    Hengyan Qu
    Dandan Li
    Mengmeng Hu
    Wenzhi Guo
    Guangbo Ge
    Ruihua Dong
    Acta Pharmaceutica Sinica B, 2017, 7 (06) : 657 - 664
  • [23] Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1
    Cheng, Xuewei
    Lv, Xia
    Qu, Hengyan
    Li, Dandan
    Hu, Mengmeng
    Guo, Wenzhi
    Ge, Guangbo
    Dong, Ruihua
    ACTA PHARMACEUTICA SINICA B, 2017, 7 (06) : 657 - 664
  • [24] Kinetic analysis of Sp1-mediated transcriptional activation of a TATA-Containing promoter
    Narayan, S
    Wilson, SH
    BIOCHEMISTRY, 2000, 39 (04) : 818 - 823
  • [25] Isolation and characterization of a TATA-less promoter for the human RAG-1 gene
    Kurioka, H
    Kishi, H
    Isshiki, H
    Tagoh, H
    Mori, K
    Kitagawa, T
    Nagata, T
    Dohi, K
    Muraguchi, A
    MOLECULAR IMMUNOLOGY, 1996, 33 (13) : 1059 - 1066
  • [26] Differential regulation of alternate UDP-glucuronosyltransferase 1A6 gene promoters by hepatic nuclear factor-1
    Auyeung, DJ
    Kessler, FK
    Ritter, JK
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2003, 191 (02) : 156 - 166
  • [27] Fuctional consequences of interindividual variation in human sulfotransferase 1A1 and UDP-glucuronosyltransferase 1A6
    Raftogianis, RB
    DRUG METABOLISM REVIEWS, 2003, 35 : 6 - 6
  • [28] Glucose induces intestinal human UDP-glucuronosyltransferase (UGT) 1A1 to prevent neonatal hyperbilirubinemia
    Aoshima, Naoya
    Fujie, Yoshiko
    Itoh, Tomoo
    Tukey, Robert H.
    Fujiwara, Ryoichi
    SCIENTIFIC REPORTS, 2014, 4
  • [29] Identification and characterization of functional hepatocyte nuclear factor 1-binding sites in UDP-glucuronosyltransferase genes
    Gardner-Stephen, DA
    Gregory, PA
    Mackenzie, PI
    PHASE II CONJUGATION ENZYMES AND TRANSPORT SYSTEMS, 2005, 400 : 22 - 46
  • [30] UDP-GLUCURONOSYLTRANSFERASE 1A1 IS THE PRINCIPAL ENZYME RESPONSIBLE FOR BAVACHININ GLUCURONIDATION IN HUMAN LIVER MICROSOMES
    Lv, Xia
    Ge, Guang-Bo
    Ning, Jing
    Hou, Jie
    Yang, Ling
    Ma, Xiao-Chi
    DRUG METABOLISM REVIEWS, 2014, 45 : 65 - 65